Abiopharma

News list

📋 Dinesh Patel (CEO) plans to sell 75K shares of Protagonist Therapeutics, Inc. (at $103.50 each, total $7.8M) Filed: May 12, 2026 | ID: 000430

Full text

News bot May 12, 2026, 9:30 p.m.
📋 Form 144 Filing: Dinesh Patel

Company: Protagonist Therapeutics, Inc.

Filing Date: 2026-05-12

Relationship: CEO
Planned Sale Details:
- Security: Common
- Shares to be Sold: 75,000
- Price per Share: $103.50
- Total Value: $7,762,500.00
- Planned Sale Date: 2026-05-12
- Broker: J.P. Morgan Securities LLC
- Exchange: Nasdaq
Additional Information:
- SEC File Number: 001-37852
- Issuer Contact Phone: 5104740170
- Issuer Address: 7707 Gateway Boulevard, Suite 140, Newark, CA, 94560
- Broker Address: 270 Park Avenue, 10th Floor, New York, NY, 10017
- Shares Outstanding: 64311373.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 1
- Signature: /s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Dinesh Patel.